Business description: TearLab Corporation

Sales by Activity: TearLab Corporation
| Fiscal Period: December | 2019 (USD) |
|---|---|
Diagnostic Kits / Equipment | 22.66M |
Geographical breakdown of sales: TearLab Corporation
| Fiscal Period: December | 2019 (USD) |
|---|---|
United States | 21.29M |
Rest of the World | 1.37M |
Executive Committee: TearLab Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Adam Szaronos
CEO | Chief Executive Officer | - | 2026-03-31 |
| Chief Tech/Sci/R&D Officer | - | 2009-07-16 | |
John Lund
DFI | Director of Finance/CFO | 60 | 2022-06-30 |
Steve Zmina
CTO | Chief Tech/Sci/R&D Officer | - | 2006-09-30 |
Michael Berg
CTO | Chief Tech/Sci/R&D Officer | 73 | - |
Composition of the Board of Directors: TearLab Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Uri Geiger
BRD | Director/Board Member | 58 | 2020-07-08 |
James V. Mazzo
CHM | Chairman | 68 | 2021-12-08 |
| Director/Board Member | 78 | 2004-08-31 | |
Dolev Rafaeli
BRD | Director/Board Member | 62 | - |
Barak Azmon
BRD | Director/Board Member | - | - |
David Carter
BRD | Director/Board Member | - | - |
Douglas Strang
BRD | Director/Board Member | - | - |
Company details: TearLab Corporation

Glasses, Spectacles & Contact Lenses
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.94% | -2.76% | -26.60% | +1.32% | 170B | ||
| -1.00% | 0.00% | -11.52% | +14.41% | 111B | ||
| -2.46% | -0.20% | -24.05% | +4.65% | 107B | ||
| -0.72% | -0.07% | -47.36% | -10.90% | 75.95B | ||
| +0.46% | +2.85% | +3.63% | +72.08% | 60.37B | ||
| -0.65% | +6.59% | +11.44% | +66.40% | 53.53B | ||
| -0.20% | -0.92% | -6.09% | -31.29% | 49.11B | ||
| -2.21% | -3.38% | -17.90% | +15.57% | 40.6B | ||
| -4.04% | -3.75% | +25.66% | +0.20% | 31.47B | ||
| Average | -1.16% | +0.25% | -10.31% | +14.72% | 77.67B | |
| Weighted average by Cap. | -0.98% | -0.04% | -16.24% | +12.17% |

















